[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

ASMB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $59,533.70

Assembly Biosciences Insider Trading History Chart

Assembly Biosciences Share Price & Price History

^$0.72

▼ -0.02 (-2.69%)

As of 11/29/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

Assembly Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/3/2023	Jason A Okazaki	CEO	Sell	2,363	$0.80	$1,890.40	174,923
10/3/2023	Nicole S White	Insider	Sell	1,891	$0.80	$1,512.80	94,251
7/24/2023	Jeanette M Bjorkquist	Insider	Sell	844	$1.07	$903.08	26,688
5/23/2023	Jason A Okazaki	CEO	Sell	6,561	$1.04	$6,823.44	126,613
5/23/2023	Jeanette M Bjorkquist	Insider	Sell	274	$1.04	$284.96	27,532
5/23/2023	John G. McHutchison	Director	Sell	25,972	$1.04	$27,010.88	169,160
3/30/2023	Jason A Okazaki	CEO	Sell	4,247	$0.82	$3,482.54	98,174
3/30/2023	Jeanette M Bjorkquist	Insider	Sell	774	$0.82	$634.68	23,806
3/30/2023	John G. McHutchison	Director	Sell	14,883	$0.82	$12,204.06	177,632
3/27/2023	Jason A Okazaki	CEO	Sell	4,693	$1.02	$4,786.86	102,421
8/8/2022	John G. McHutchison	CEO	Sell	12,314	$2.13	$26,228.82	192,515
7/25/2022	Michael P Samar	CFO	Sell	2,020	$2.22	$4,484.40	77,228
5/31/2022	William E Iv Delaney	Insider	Sell	4,164	$1.92	$7,994.88	76,419
3/30/2022	Jason A Okazaki	COO	Sell	1,269	$2.17	$2,753.73
3/30/2022	John G. McHutchison	CEO	Sell	4,614	$2.17	$10,012.38
3/30/2022	Luisa M Stamm	Insider	Sell	1,038	$2.17	$2,252.46
3/30/2022	Michael P Samar	CFO	Sell	2,285	$2.17	$4,958.45
3/28/2022	Jason A Okazaki	COO	Sell	4,617	$2.24	$10,342.08
8/9/2021	John G. McHutchison	CEO	Sell	12,156	$3.60	$43,761.60
5/27/2021	William E. lv Delaney	Insider	Sell	4,129	$4.03	$16,639.87
12/14/2020	Jacqueline Sybil Papkoff	SVP	Sell	1,297	$6.15	$7,976.55	37,364

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Assembly Biosciences (NASDAQ:ASMB)

19.92% of Assembly Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Assembly Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/13/2023	Acadian Asset Management LLC	83,470	$73K	0.0%	-26.7%	0.127%
8/15/2023	Hudson Bay Capital Management LP	826,255	$0.95M	0.0%	-13.0%	1.571%
8/11/2023	Renaissance Technologies LLC	698,000	$0.80M	0.0%	-8.9%	1.339%
8/11/2023	BlackRock Inc.	1,070,324	$1.23M	0.0%	-1.5%	2.054%
8/11/2023	Geode Capital Management LLC	507,649	$0.58M	0.0%	+12.2%	0.974%
8/11/2023	Northern Trust Corp	108,116	$0.12M	0.0%	+9.9%	0.207%
8/7/2023	Acadian Asset Management LLC	113,854	$0.13M	0.0%	-27.7%	0.218%
5/16/2023	Hudson Bay Capital Management LP	950,000	$0.80M	0.0%	-7.3%	1.823%
5/15/2023	Two Sigma Investments LP	38,303	$32K	0.0%	N/A	0.073%
5/12/2023	Renaissance Technologies LLC	765,800	$0.64M	0.0%	+52.1%	1.469%
5/12/2023	BlackRock Inc.	1,086,563	$0.91M	0.0%	-4.3%	2.085%
5/12/2023	Dimensional Fund Advisors LP	284,185	$0.24M	0.0%	-11.9%	0.545%
5/12/2023	Platinum Investment Management Ltd.	890,736	$0.75M	0.0%	-18.6%	1.709%
5/11/2023	Acadian Asset Management LLC	157,549	$0.13M	0.0%	-38.7%	0.302%
5/11/2023	FMR LLC	157,700	$0.13M	0.0%	+7.7%	0.303%
5/9/2023	Tower Research Capital LLC TRC	31,160	$26K	0.0%	-39.2%	0.060%
5/8/2023	Federated Hermes Inc.	363,023	$0.31M	0.0%	-2.8%	0.699%
2/15/2023	Jane Street Group LLC	76,961	$100K	0.0%	+587.6%	0.158%
2/15/2023	Millennium Management LLC	1,497,606	$1.95M	0.0%	-3.2%	3.070%
2/15/2023	Morgan Stanley	31,378	$41K	0.0%	-42.7%	0.064%
2/14/2023	Susquehanna International Group LLP	21,255	$28K	0.0%	-37.7%	0.044%
2/13/2023	Platinum Investment Management Ltd.	1,094,770	$1.42M	0.1%	-24.5%	2.244%
2/13/2023	Renaissance Technologies LLC	503,384	$0.65M	0.0%	+78.4%	1.032%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	65,393	$85K	0.0%	-49.6%	0.134%
2/10/2023	Franklin Resources Inc.	82,645	$0.11M	0.0%	+116.6%	0.169%
2/9/2023	Dimensional Fund Advisors LP	322,688	$0.42M	0.0%	-2.3%	0.662%
2/8/2023	UBS Group AG	24,007	$31K	0.0%	+110.0%	0.049%
11/15/2022	Two Sigma Advisers LP	64,800	$0.11M	0.0%	-33.0%	0.133%
11/15/2022	Two Sigma Investments LP	32,067	$53K	0.0%	-48.6%	0.066%
11/15/2022	Vanguard Group Inc.	2,202,792	$3.61M	0.0%	-2.3%	4.516%
11/15/2022	Platinum Investment Management Ltd.	1,450,328	$2.38M	0.1%	-8.9%	2.973%
11/15/2022	BlackRock Inc.	1,133,884	$1.86M	0.0%	-2.0%	2.324%
11/15/2022	Citadel Advisors LLC	27,382	$45K	0.0%	-86.6%	0.056%
11/15/2022	Commonwealth Equity Services LLC	18,648	$30K	0.0%	-27.6%	0.038%
11/14/2022	Cubist Systematic Strategies LLC	19,857	$33K	0.0%	-31.4%	0.041%
11/14/2022	Renaissance Technologies LLC	282,200	$0.46M	0.0%	+24.2%	0.579%
11/14/2022	Healthcare of Ontario Pension Plan Trust Fund	570,300	$0.94M	0.0%	N/A	1.169%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	129,752	$0.21M	0.0%	-9.2%	0.268%
11/10/2022	Dimensional Fund Advisors LP	330,159	$0.54M	0.0%	-7.0%	0.682%
11/10/2022	Tower Research Capital LLC TRC	17,150	$28K	0.0%	+110.2%	0.035%
11/7/2022	Virtu Financial LLC	30,046	$49K	0.0%	N/A	0.062%
11/3/2022	Barclays PLC	37,194	$61K	0.0%	-76.9%	0.077%
10/27/2022	Assenagon Asset Management S.A.	253,783	$0.42M	0.0%	-62.9%	0.524%
9/16/2022	Federated Hermes Inc.	373,665	$0.79M	0.0%	-2.0%	0.771%
8/18/2022	Goldman Sachs Group Inc.	76,767	$0.16M	0.0%	-38.0%	0.158%
8/16/2022	Jane Street Group LLC	30,452	$64K	0.0%	+134.5%	0.063%
8/16/2022	Prudential Financial Inc.	16,980	$36K	0.0%	N/A	0.035%
8/15/2022	Cubist Systematic Strategies LLC	28,961	$61K	0.0%	N/A	0.060%
8/15/2022	Millennium Management LLC	1,418,180	$2.98M	0.0%	+3.9%	2.928%
8/13/2022	Renaissance Technologies LLC	227,300	$0.48M	0.0%	+67.3%	0.471%
8/12/2022	Franklin Resources Inc.	37,745	$79K	0.0%	-32.6%	0.078%
8/11/2022	Platinum Investment Management Ltd.	1,591,272	$3.34M	0.1%	-16.7%	3.300%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	142,915	$0.30M	0.0%	-13.4%	0.296%
7/27/2022	Assenagon Asset Management S.A.	684,846	$1.44M	0.0%	+1,422.3%	1.420%
7/19/2022	Commonwealth Equity Services LLC	25,749	$54K	0.0%	+30.4%	0.053%
6/7/2022	Bank of America Corp DE	31,561	$65K	0.0%	+299.2%	0.065%
5/17/2022	Jane Street Group LLC	12,987	$27K	0.0%	N/A	0.027%
5/16/2022	Goldman Sachs Group Inc.	123,772	$0.26M	0.0%	+123.6%	0.257%
5/16/2022	State Street Corp	145,335	$0.30M	0.0%	+15.7%	0.302%
5/16/2022	Eversept Partners LP	280,000	$0.58M	0.0%	-9.7%	0.582%
5/13/2022	Renaissance Technologies LLC	135,900	$0.28M	0.0%	-79.7%	0.282%
5/13/2022	Northern Trust Corp	92,702	$0.19M	0.0%	-9.6%	0.193%
5/13/2022	Charles Schwab Investment Management Inc.	51,368	$0.11M	0.0%	N/A	0.107%
5/13/2022	Federated Hermes Inc.	381,299	$0.79M	0.0%	-30.0%	0.792%
5/13/2022	Vanguard Group Inc.	1,628,318	$3.35M	0.0%	-26.2%	3.384%
5/13/2022	Dimensional Fund Advisors LP	381,060	$0.79M	0.0%	-31.1%	0.792%
5/12/2022	BlackRock Inc.	1,163,520	$2.40M	0.0%	-2.0%	2.418%
5/12/2022	Acadian Asset Management LLC	927,402	$1.91M	0.0%	-42.4%	1.927%
5/11/2022	JPMorgan Chase & Co.	14,789	$30K	0.0%	+15,633.0%	0.031%
5/11/2022	GSA Capital Partners LLP	135,834	$0.28M	0.0%	N/A	0.282%
4/26/2022	Marquette Asset Management LLC	58,246	$0.12M	0.0%	+21.3%	0.121%
4/25/2022	Assenagon Asset Management S.A.	44,987	$93K	0.0%	N/A	0.093%
2/14/2022	Deep Track Capital LP	3,000,000	$6.99M	0.5%	N/A	6.268%
2/14/2022	Eversept Partners LP	310,000	$0.72M	0.1%	-11.4%	0.648%
2/10/2022	Candriam Luxembourg S.C.A.	1,838,221	$4.28M	0.0%	+25.1%	3.841%
2/10/2022	Acadian Asset Management LLC	1,608,760	$3.75M	0.0%	+13.9%	3.361%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	170,216	$0.40M	0.0%	+8.8%	0.356%
2/9/2022	Dimensional Fund Advisors LP	553,428	$1.29M	0.0%	+54.0%	1.156%
1/21/2022	Russell Investments Group Ltd.	123,748	$0.29M	0.0%	+41.2%	0.259%
1/19/2022	Marquette Asset Management LLC	48,000	$0.11M	0.0%	+73.7%	0.100%
12/29/2021	Hudson Bay Capital Management LP	850,000	$2.96M	0.0%	+13.3%	1.776%
11/16/2021	Two Sigma Advisers LP	348,700	$1.21M	0.0%	-53.9%	0.729%
11/15/2021	Hudson Bay Capital Management LP	850,000	$2.96M	0.0%	+13.3%	1.776%
11/15/2021	Eversept Partners LP	350,000	$1.22M	0.1%	N/A	0.731%
11/15/2021	Dimensional Fund Advisors LP	359,315	$1.25M	0.0%	-23.4%	0.751%
11/15/2021	Franklin Resources Inc.	584,688	$2.04M	0.0%	+10.6%	1.222%
11/12/2021	Renaissance Technologies LLC	130,600	$0.45M	0.0%	-63.3%	0.273%
11/12/2021	Prosight Management LP	265,634	$0.92M	0.5%	+78.2%	0.555%
11/12/2021	Geode Capital Management LLC	525,263	$1.83M	0.0%	+11.2%	1.097%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	156,415	$0.54M	0.0%	+3.1%	0.327%
11/10/2021	Goldman Sachs Group Inc.	131,367	$0.46M	0.0%	-30.8%	0.292%
11/10/2021	IndexIQ Advisors LLC	97,739	$0.34M	0.0%	+11.1%	0.204%
11/9/2021	Barclays PLC	212,980	$0.74M	0.0%	+31.3%	0.445%
11/9/2021	BlackRock Inc.	1,969,977	$6.86M	0.0%	+3.0%	4.116%
11/9/2021	Candriam Luxembourg S.C.A.	1,468,846	$5.11M	0.0%	+31.9%	3.069%
11/8/2021	Russell Investments Group Ltd.	87,636	$0.30M	0.0%	+72.7%	0.195%
10/12/2021	Marquette Asset Management LLC	27,641	$96K	0.0%	+21.8%	0.061%
9/17/2021	Virtu Financial LLC	64,020	$0.25M	0.0%	N/A	0.142%
9/3/2021	Parametric Portfolio Associates LLC	89,340	$0.35M	0.0%	+106.5%	0.199%
8/17/2021	Raffles Associates LP	100,000	$0.39M	0.3%	+100.0%	0.222%

Data available starting January 2016

Assembly Biosciences, Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's next-generation HBV core inhibitors include ABI-4334, which is in Phase 1a studies for the treatment of HBV; and ABI-H3733, which is in Phase 1b clinical study. It is also involved in novel small molecule approaches for HBV and hepatitis delta virus (HDV) comprising an orally bioavailable HBV/HDV entry inhibitor and liver-focused interferon-a receptor agonist. In addition, the company develops Herpesvirus programs, such as ABI-5366 HSV-2, a long-acting helicase inhibitor; and pan-herpes non-nucleoside polymerase inhibitors for transplant-associated infections. Further, Assembly Biosciences, Inc. has collaboration agreement with BeiGene, Ltd. to develop and commercialize the novel core inhibitor product candidates for chronic HBV infection in the People's Republic of China, Hong Kong, Taiwan, and Macau; and clinical trial collaboration agreement with Arbutus Biopharma Corporation to conduct a randomized, multi-center, and open-label clinical trials, as well as agreement with Antios Therapeutics, Inc. for triple combination therapy. The company also has license agreement with Indiana University Research and Technology Corporation for HBV research, as well as a partnership with Gilead Sciences, Inc. to develop next-generation therapeutics for serious viral diseases. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Today's Range

Now: $0.72

$0.69

$0.77

50 Day Range

MA: $0.82

$0.65

$1.25

52 Week Range

Now: $0.72

$0.64

$1.78

Volume

444,113 shs

Average Volume

667,151 shs

Market Capitalization

$47.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.61

Who are the company insiders with the largest holdings of Assembly Biosciences?: Assembly Biosciences' top insider investors include:
John G Mchutchison (CEO)
John G Mchutchison (Director)
Jason A Okazaki (CEO)
Nicole S White (Insider)
Michael P Samar (CFO)
William E Iv Delaney (Insider)
Jeanette M Bjorkquist (Insider)
Jason A Okazaki (COO)
Luisa M Stamm (Insider)
Learn More about top insider investors at Assembly Biosciences.
Who are the major institutional investors of Assembly Biosciences?: Assembly Biosciences' top institutional shareholders include:
Acadian Asset Management LLC — 0.13%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Assembly Biosciences stock.
Which major investors are selling Assembly Biosciences stock?: Within the previous quarter, ASMB stock was sold by these institutional investors:
Acadian Asset Management LLC
In the previous year, company insiders that have sold Assembly Biosciences company stock include:
John G Mchutchison (CEO)
John G Mchutchison (Director)
Jason A Okazaki (CEO)
Nicole S White (Insider)
Learn More investors selling Assembly Biosciences stock.

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

ASMB Insider Trading

Assembly Biosciences Insider Trading History Chart

Assembly Biosciences Share Price & Price History

Assembly Biosciences Insider Trading History

SEC Filings (Institutional Ownership Changes) for Assembly Biosciences (NASDAQ:ASMB)

Institutional Buying and Selling by Quarter

Assembly Biosciences Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Assembly Biosciences?

Who are the major institutional investors of Assembly Biosciences?

Which major investors are selling Assembly Biosciences stock?